A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream

Clinical trial NCT03462927 · COMPLETED

Trial details

NCT number: NCT03462927
Sponsor: MC2 Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis Vulgaris

Start date: 2018-02-08
Primary completion: 2018-08-04
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.